ArticleThoracic cancer2025
Effect of Particulate Matter Pollution on Global Lung Cancer Burden: A Systematic Analysis for the Global Burden of Disease Study 1990-2021.
Article in Thoracic cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundLung cancer remains a leading cause of cancer mortality globally, with particulate matter pollution (PMP) identified as a critical environmental risk. This study analyzes long-term trends in age-standardized mortality (ASMR) and disability-adjusted life-year rates (ASDR) for PMP-attributable lung cancer, with projections to 2030.
methodUsing Global Burden of Disease data, we evaluated temporal trends across age, sex, and Sociodemographic Index (SDI) regions through age-period-cohort and Bayesian models.
resultGlobal Trends: PMP-related ASMR/ASDR declined significantly over the study period, while ambient PMP (APMP)-attributable rates increased, contrasting with household air pollution (HAP)-related declines. Age and Sex Disparities: Mortality burden shifted toward older populations, with APMP-related deaths rising sharply in the elderly. Males exhibited faster declines in PMP/HAP-related mortality, whereas females faced steeper increases in APMP-attributable risks. SDI variations: High-middle SDI regions consistently had the highest PMP-related mortality, with ASMR trends reflecting industrialization phases. Projections: PMP-related burdens are expected to rise globally, driven by aging populations and persistent pollution in middle-SDI regions.
conclusionThe escalating burden in vulnerable populations demands urgent interventions, including air quality improvement, tobacco control, and enhanced screening, Notably, China consistently exhibited the world's highest PMP-attributable lung cancer ASMR (13.6 per 100 000 in 1990, declining to 10.1 per 100 000 in 2021). Future strategies must integrate gender-specific risk mitigation and environmental-genetic assessments to address disparities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.